Schedule 13G ownership disclosure

OKYO PHARMA LTD

Common · CUSIP: G6724L116

Event date: 2025-09-30

Filing-level shares
2,984,862.00
Percent of class
7.8%
  • Chernett Jorey

    Shares: 2,984,862.00 · Class: 7.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002042077-25-000008
Form type
SCHEDULE 13G/A
Filer
Chernett Jorey
CIK
CIK 2042077
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub